BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 7489980)

  • 1. Screening for hemochromatosis in children of homozygotes: prevalence and cost-effectiveness.
    Adams PC; Kertesz AE; Valberg LS
    Hepatology; 1995 Dec; 22(6):1720-7. PubMed ID: 7489980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening blood donors for hereditary hemochromatosis: decision analysis model based on a 30-year database.
    Adams PC; Gregor JC; Kertesz AE; Valberg LS
    Gastroenterology; 1995 Jul; 109(1):177-88. PubMed ID: 7797016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of hemochromatosis among 11,065 presumably healthy blood donors.
    Edwards CQ; Griffen LM; Goldgar D; Drummond C; Skolnick MH; Kushner JP
    N Engl J Med; 1988 May; 318(21):1355-62. PubMed ID: 3367936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening blood donors for hereditary hemochromatosis: decision analysis model comparing genotyping to phenotyping.
    Adams PC; Valberg LS
    Am J Gastroenterol; 1999 Jun; 94(6):1593-600. PubMed ID: 10364030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Genetic hemochromatosis: importance of population screening?].
    Cartabellotta A; Montalto G
    Recenti Prog Med; 1996 Mar; 87(3):118-23. PubMed ID: 8650432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness of screening for hereditary hemochromatosis.
    Phatak PD; Guzman G; Woll JE; Robeson A; Phelps CE
    Arch Intern Med; 1994 Apr; 154(7):769-76. PubMed ID: 8147681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening for hemochromatosis in asymptomatic subjects with or without a family history.
    Powell LW; Dixon JL; Ramm GA; Purdie DM; Lincoln DJ; Anderson GJ; Subramaniam VN; Hewett DG; Searle JW; Fletcher LM; Crawford DH; Rodgers H; Allen KJ; Cavanaugh JA; Bassett ML
    Arch Intern Med; 2006 Feb; 166(3):294-301. PubMed ID: 16476869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemochromatosis screening in asymptomatic ambulatory men 30 years of age and older.
    Baer DM; Simons JL; Staples RL; Rumore GJ; Morton CJ
    Am J Med; 1995 May; 98(5):464-8. PubMed ID: 7733125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnosis of hemochromatosis in young subjects: predictive accuracy of biochemical screening tests.
    Bassett ML; Halliday JW; Ferris RA; Powell LW
    Gastroenterology; 1984 Sep; 87(3):628-33. PubMed ID: 6745616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Importance of establishing appropriate local reference values for the screening of hemochromatosis: a study of three different control populations and 136 hemochromatosis family members. Hemochromatosis Clinical and Research Group.
    Porto G; Vicente C; Fraga J; da Silva BM; de Sousa M
    J Lab Clin Med; 1992 Mar; 119(3):295-305. PubMed ID: 1541878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic efficacy of screening tests for hereditary hemochromatosis.
    Borwein S; Ghent CN; Valberg LS
    Can Med Assoc J; 1984 Oct; 131(8):895-901. PubMed ID: 6593112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hereditary hemochromatosis screening: effect of mutation penetrance and prevalence on cost-effectiveness of testing algorithms.
    Gagné G; Reinharz D; Laflamme N; Adams PC; Rousseau F
    Clin Genet; 2007 Jan; 71(1):46-58. PubMed ID: 17204047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of transferrin saturation as a screening test for hereditary haemochromatosis in an Irish population seeking medical care.
    O'Hara R; Cavanagh N; Cassidy M; Cullina M
    Ann Clin Biochem; 2003 Mar; 40(Pt 2):169-74. PubMed ID: 12662406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of idiopathic hemochromatosis in Italy: study of 1301 blood donors.
    Velati C; Piperno A; Fargion S; Colombo S; Fiorelli G
    Haematologica; 1990; 75(4):309-12. PubMed ID: 2276675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Searching for hereditary hemochromatosis.
    Laudicina RJ
    Clin Lab Sci; 2006; 19(3):174-83. PubMed ID: 16910235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of silent liver fibrosis in hemochromatosis C282Y homozygotes with normal transaminase levels.
    Beaton M; Adams PC
    Clin Gastroenterol Hepatol; 2008 Jun; 6(6):713-4. PubMed ID: 18550006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening for hemochromatosis: phenotype versus genotype.
    Edwards CQ; Griffen LM; Ajioka RS; Kushner JP
    Semin Hematol; 1998 Jan; 35(1):72-6. PubMed ID: 9460810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic screening for HFE hemochromatosis in 6,020 Danish men: penetrance of C282Y, H63D, and S65C variants.
    Pedersen P; Milman N
    Ann Hematol; 2009 Aug; 88(8):775-84. PubMed ID: 19159930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening for hereditary hemochromatosis in prospective blood donors.
    Benn HP; Nielsen P; Fischer R; Schwarz D; Engelhardt R; Darda C; Dittmer R; Knödler B; Gabbe EE; Kühnl P
    Beitr Infusionsther Transfusionsmed; 1994; 32():314-6. PubMed ID: 9422115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hemochromatosis--from an underdiagnosed curiosity to a common disease].
    Hagve TA; Asberg A; Ulvik R; Borch-Iohnsen B; Thorstensen K
    Tidsskr Nor Laegeforen; 2009 Apr; 129(9):863-6. PubMed ID: 19415085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.